收藏切换
Effects of paricalcitol combined with valsartan on renal fibrosis indexes, high mobility group protein B1 and nuclear factor-κB in patients with diabetic nephropathy
收藏切换
Wenjuan ZHAO1, Shiguo XIA2, *
World Clinical Drug | 2022, 43(11) : 1440 - 1445
Less
收藏切换
World Clinical Drug | 2022, 43(11): 1440-1445
• Article •
Effects of paricalcitol combined with valsartan on renal fibrosis indexes, high mobility group protein B1 and nuclear factor-κB in patients with diabetic nephropathy
Full
Wenjuan ZHAO1, Shiguo XIA2, *
Affiliations
  • 1.Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201499, China
  • 2.Department of Renal Rheumatology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201499, China
Published: 2022-11-10 doi: 10.13683/j.wph.2022.11.009
Outline
收藏切换
Objective

To explore the effects of paricalcitol combined with valsartan on levels of renal fibrosis indexes, high mobility group protein (HMG) B1 and nuclear transcription factor (NF)-κB in patients with diabetic nephropathy (DN).

Methods

A total of 120 patients with DN admitted to the outpatient of Shanghai Jiao Tong university affiliated sixth people's hospital south campus were enrolled from May 2020 to May 2021. According to random number table method, they were divided into paricalcitol group (paricalcitol), valsartan group (valsartan) and combination group (paricalcitol combined with valsartan), 40 cases in each group. After 1 month of continuous treatment, clinical curative effect and levels of renal function indexes [β2 microglobulin (β2M), creatinine (Cr)], renal fibrosis indexes [cystatin (Cys) C, tissue inhibitor of metalloproteinase (TIMP)-1], HMGB1 and NF-κB in different groups were compared. The occurrence of adverse reactions during treatment was recorded in each group.

Results

The total effective rate of combination group was higher than that in paricalcitol group (87.50% vs 65.00%, P<0.05). After treatment, the levels of β2M, Cr, CysC, TIMP-1, HMGB1 and NF-κB in combination group were lower than those in valsartan group and paricalcitol group (P<0.05).

Conclusion

Compared with paricalcitol monotherapy, paricalcitol combined with valsartan has better effect of on DN, which can effectively improve renal function, delay renal fibrosis and better regulate the levels of HMGB1 and NF-κB.

paricalcitol  /  valsartan  /  diabetic nephropathy  /  renal fibrosis
赵文娟, 夏世国. 帕立骨化醇联合缬沙坦对糖尿病肾病患者肾纤维化指标及高迁移率族蛋白B1、核转录因子-κB水平的影响. 世界临床药物, 2022 , 43 (11) : 1440 -1445 . DOI: 10.13683/j.wph.2022.11.009
Wenjuan ZHAO, Shiguo XIA. Effects of paricalcitol combined with valsartan on renal fibrosis indexes, high mobility group protein B1 and nuclear factor-κB in patients with diabetic nephropathy[J]. World Clinical Drug, 2022 , 43 (11) : 1440 -1445 . DOI: 10.13683/j.wph.2022.11.009
Year 2022 volume 43 Issue 11
4
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.11.009
  • Receive Date:2022-05-28
  • Online Date:2026-11-18
  • Published:2022-11-10
Article Data
Affiliations
History
  • Received:2022-05-28
  • Revised:2022-08-12
Funding
Affiliations
    1.Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201499, China
    2.Department of Renal Rheumatology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai 201499, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.11.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT